© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

International issuers crowd into Swiss francs

Foreign corporate issuance running at record high
AI issuance is becoming increasingly concentrated — beware

ING banker moves to Asian Development Bank

Recently departed banker to resurface in Asia

Csquare's IPO to chip away at $3bn of ABS debt

IPO documents reveal data center portfolio purchase
AI issuance is becoming increasingly concentrated — beware
Sub-sections
  • India’s Glenmark Life Sciences, a pharmaceutical ingredients maker, has filed draft paperwork for an IPO of new and existing shares.
  • Chinese company Zhaoke Ophthalmology has kicked off a Hong Kong IPO worth up to HK$2.1bn ($270m), becoming the latest biotechnology company to sell shares on the bourse.
  • More than 90% of Suriname’s bondholders this week participated in a consent solicitation that extends the sovereign’s debt standstill until the end of July. But the government has only until April 30 to sign a deal with the IMF, or the standstill will be cancelled.